BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28129717)

  • 21. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Migraine and contraception].
    Cappy H; Lucas C; Catteau-Jonard S; Robin G
    Gynecol Obstet Fertil; 2015 Mar; 43(3):234-41. PubMed ID: 25727163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
    Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y
    Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine.
    Merki-Feld GS; Imthurn B; Seifert B; Merki LL; Agosti R; Gantenbein AR
    Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):394-400. PubMed ID: 23927694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Headache, menstruation and combined oral contraceptives: a diary study in 184 women with migraine.
    Lieba-Samal D; Wöber C; Frantal S; Brannath W; Schmidt K; Schrolnberger C; Wöber-Bingöl C;
    Eur J Pain; 2011 Sep; 15(8):852-7. PubMed ID: 21402485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The statement of Polish Gynecological Society experts on oral use of contraceptive 75 microg desogestrel minipill in different clinical cases--state of art in 2008].
    Debski R; Kotarski J; Paszkowski T; Pawelczyk L; Skrzypulec V; Tomaszewski J;
    Ginekol Pol; 2009 Jan; 80(1):63-75. PubMed ID: 19323063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of progestogen-only pill in migraine patients.
    Allais G; Chiarle G; Bergandi F; Benedetto C
    Expert Rev Neurother; 2016; 16(1):71-82. PubMed ID: 26630354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits of progestin contraception in non-allergic angioedema.
    Saule C; Boccon-Gibod I; Fain O; Kanny G; Plu-Bureau G; Martin L; Launay D; Bouillet L; Gompel A
    Clin Exp Allergy; 2013 Apr; 43(4):475-82. PubMed ID: 23517043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease?
    Merki-Feld GS; Bitzer J
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):213-220. PubMed ID: 32336145
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
    Calhoun A; Ford S; Pruitt A
    Headache; 2012 Sep; 52(8):1246-53. PubMed ID: 22789073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sexuological impact of hormonal contraceptives based on their route of administration.
    Guida M; Di Carlo C; Troisi J; Gallo A; Cibarelli F; Martini E; Tiranini L; Nappi RE
    Gynecol Endocrinol; 2017 Mar; 33(3):218-222. PubMed ID: 27908210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen-free oral hormonal contraception: benefits of the progestin-only pill.
    de Melo NR
    Womens Health (Lond); 2010 Sep; 6(5):721-35. PubMed ID: 21080791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined hormonal contraceptives: is it time to reassess their role in migraine?
    Calhoun A
    Headache; 2012 Apr; 52(4):648-60. PubMed ID: 22221001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
    Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
    Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.